|
|
|
 |
|
Increased intake of carotenoids and fish oil doesn't reduce AMD risk further
|
Increased oral supplementation of carotenoids (lutein and zeaxanthin) and omega-3 fatty acids, found in fish oil, does not reduce the risk of AMD progression further to the original AREDS formulation, claims the latest results of the Age-Related Eye Disease Study (AREDS2).
|
|
|
|
Laser confocal imaging useful for AMD
|
|
Scanning laser ophthalmoscopy with a lateral confocal aperture could highlight subclinical drusen and aid in the progression of monitoring in AMD patients, claims the latest paper in the British Journal of Ophthalmology.
|
|
|
|
Kaiser study results on ranibizumab and bevacizumab
|
|
A Kaiser Permanents Southern California study published in this month?s Ophthalmology, the journal of the American Academy of Ophthalmology, compares ranibizumab (Lucentis) and bevacizumab (Avastin) and found them to be equally effective in halting vision loss.
|
|
|
|
First ever sham-controlled study of radiation therapy for wet AMD initiated by Oraya Therapeutics
|
|
)? Oraya Therapeutics, Inc., announced today that enrollment is now underway for the first ever masked and sham-controlled study to demonstrate the efficacy and safety of radiation therapy for the treatment of wet age-related macular degeneration (AMD). The groundbreaking clinical trial is being conducted at seven European sites, and will include a minimum of 150 patients, with approximately one third of those receiving a sham exposure and the remainder receiving radiation dosing of either 16 or 24 Gray (GY).
|
|
|
|
Visudyne evaluation indicates positive results
|
|
Positive twelve-month primary analysis results from the Phase II RADICAL study (Reduced Fluence Visudyne Anti-VEGF-Dexamethasone In Combination for AMD Lesions) in patients with wet age-related macular degeneration (wet AMD) have been announced by QLT Inc.
|
|
|
|
Gene genie collaboration
|
|
A new collaboration between Oxford BioMedica and Sanofi-Aventis is to develop and commercialise gene therapy treatments for retinal degenerative diseases such as Stargardt disease, the form of early-onset macular degeneration and Usher syndrome, a relatively rare genetic disease where sufferers are born deaf and lose vision within the first 10 years of life.
|
|
|
|
The IOL-VIP system: restoring sight to AMD patients
|
|
Dr José Luis Menezo looks at improving the visual acuity of patients with age-related macular degeneration (AMD) using an IOL-Vip system.
|
|
|
|
Treating wet AMD with radiation
|
|
A single procedure may be as effective as repeated anti-VEGF injections claims Timothy L. Jackson.
|
|
|
|
Eye drops: a breakthrough in dry AMD treatment?
|
|
Paul Sternberg assesses the new approaches and exciting pipeline of potential dry AMD treatments.
|
|
|
 MORE ARTICLES
|
|
|
|
Increased intake of carotenoids and fish oil doesn't reduce AMD risk further
|
|
Increased oral supplementation of carotenoids (lutein and zeaxanthin) and omega-3 fatty acids, found in fish oil, does not reduce the risk of AMD progression further to the original AREDS formulation, claims the latest results of the Age-Related Eye Disease Study (AREDS2).
|
|
|
|
Laser confocal imaging useful for AMD
|
|
Scanning laser ophthalmoscopy with a lateral confocal aperture could highlight subclinical drusen and aid in the progression of monitoring in AMD patients, claims the latest paper in the British Journal of Ophthalmology.
|
|
|
|
Macular translocation is still effective after five years
|
|
It is possible for AMD patients to maintain BCVA for fives years after macular translocation surgery..
|
|
|
|
Cases of peripheral yellow corneal rings of AMD revealed
|
|
Peripheral yellow corneal rings are more common in age-related macular degeneration (AMD).
|
|
|
|
Implantable telescope finally gets FDA approval
|
|
VisionCare&#;s implantable telescope for end-stage AMD has finally been given FDA approval. The device, discussed in depth in Ophthalmology Times Europe July 2007, was given CE approval three years ago but has subsequently been undergoing rigorous clinical trials in the United States.
|
|
|
|
IRay stereotactic radiotherapy system gets European CE mark
|
|
Oraya Therapeutics has been granted the CE mark for its IRay system, which its researchers say can deliver low-energy X-rays to treat wet AMD.
|
|
|
|
First ever sham-controlled study of radiation therapy for wet AMD initiated by Oraya Therapeutics
|
|
)? Oraya Therapeutics, Inc., announced today that enrollment is now underway for the first ever masked and sham-controlled study to demonstrate the efficacy and safety of radiation therapy for the treatment of wet age-related macular degeneration (AMD). The groundbreaking clinical trial is being conducted at seven European sites, and will include a minimum of 150 patients, with approximately one third of those receiving a sham exposure and the remainder receiving radiation dosing of either 16 or 24 Gray (GY).
|
|
|
|
Cancer drug no different in effectiveness as gold standard treatment for macular degeneration
|
|
Investigators from Boston University School of Medicine (BUSM) and the VA Boston Healthcare System have shown, at 6 months in a small group of patients, that there is no difference in efficacy between Bevacizumab (Avastin) and Ranibizumab (Lucentis) for the treatment of age-related macular degeneration (AMD).
|
|
|
|
Early AMD associated with coronary heart disease
|
|
The results of a study published in the July issue of Ophthalmology has discovered that people in the early stages of age-related macular degeneration (AMD) are at a higher risk of developing coronary heart disease (CHD), offering further support to the theory that AMD is associated with underlying systemic vascular disease.
|
|
|
|
MORE ARTICLES
|
|
|
|
|
|
|
|
RDO patient pathway improves operative rates in cataracts
|
|
Operative rates for cataract surgery are higher for the refined direct optometrist (RDO) patient pathway, compared to the GP pathway, reveals a recent investigation in the UK.
|
|
|
|
Piggyback toric IOL effective for astigmatism
|
|
Implanting a customized primary or a secondary piggyback toric IOL post-penetrating keratoplasty (PK) is effective for astigmatism, claims a paper in Eye.
|
|
|
|
Excellent visual outcomes in cataract surgery
|
|
Cataract surgery produces excellent visual outcomes, with 61.3% of patients achieving a corrected distance visual acuity of 20/20 or better, according to a database study in the Journal of Cataract and Refractive Surgery.
|
|
|
|
FS-laer assisted intrastomal arcuate keratotomy a success
|
|
Intrastromal arcuate keratotomy performed with a femtosecond (FS) laser has an excellent safety profile, rapid recovery and stability of vision, claims a new paper.
|
|
|
|
Multifocal diffractive add-on IOL suitable alternative
|
|
Multifocal diffractive add-on IOL is a suitable alternative to standard multifocal IOLs for sulcus fixation.
|
|
|
|
Multicomponent IOL provides excellent vision
|
|
Multicomponent IOL implantation is safe, easy and provides excellent vision, according to a recent case series.
|
|
|
|
Risk factors for esotropia reoperation revealed
|
|
Underaction of the lateral rectus muscle could be a risk factor for reoperation of congenital esostropia, claims an investigation in the Journal of Pediatric Ophthalmology and Strabismus.
|
|
|
|
Caution needed for full correction in low astigmatism
|
|
Caution should be used when considering full astigmatic correction for manifest cylinder of 0.5 D or less in myopic patients, according to the latest investigation in the Journal of Cataract and Refractive Surgery.
|
|
|
|
ECD not linked to CCT in keratoconus
|
|
Corneal endothelial cell density (ECD) changes are independent from central corneal thickness (CCT) in keratoconus patients, states a recent paper.
|
|
|
|
MORE ARTICLES
|
|
|
|
|
|
Macular thickness increases after cataract surgery
|
|
Macular thickness significantly increases up to six months after uncomplicated cataract surgery, according to an investigation featured in the journal Eye.
|
|
|
|
RDO patient pathway improves operative rates in cataracts
|
|
Operative rates for cataract surgery are higher for the refined direct optometrist (RDO) patient pathway, compared to the GP pathway, reveals a recent investigation in the UK.
|
|
|
|
Excellent visual outcomes in cataract surgery
|
|
Cataract surgery produces excellent visual outcomes, with 61.3% of patients achieving a corrected distance visual acuity of 20/20 or better, according to a database study in the Journal of Cataract and Refractive Surgery.
|
|
|
|
ECD not linked to CCT in keratoconus
|
|
Corneal endothelial cell density (ECD) changes are independent from central corneal thickness (CCT) in keratoconus patients, states a recent paper.
|
|
|
|
Loteprednol etabonate controls inflammation and IOP
|
|
Loteprednol etabonate controls inflammation and reduces IOP fluctuation after cataract surgery, according to a recent study.
|
|
|
|
Optos urges skiers to consider eye health
|
|
Optos is urging skiers to ensure they take care of their eyesight while on the slopes this winter, according to their latest press release.
|
|
|
|
Gel cuts inflammation and pain
|
|
Loteprednol etabonate gel 0.5% is efficacious and safe for treating postoperative inflammation and pain caused by cataract surgery, claims a recent report.
|
|
|
|
Povidone-iodine and antibiotics effective for cataract surgery
|
|
Preoperative povidone-iodine and postoperative intracameral antibiotic injections are recommended for endophthalmitis prophylaxis, claims a recent paper.
|
|
|
|
MICS IOL modification does not affect PCO
|
|
Modifying a MICS IOL from a 3-piece to a 1-piece haptic design does not cause any significant changes in PCO amount.
|
|
|
|
MORE ARTICLES
|
|
|
|
Corneal degeneration is more common in white women
|
|
Peripheral hypertrophic subepithelial corneal degeneration is an uncommon disorder that occurs mostly in white women with a distinct phenotype, claims a study in the journal Ophthalmology.
|
|
|
|
Visual acuity poorly linked to GT after DSAEK
|
|
Visual acuity poorly correlates to graft thickness (GT) in patients who underwent descemet stripping automated endothelial keratoplasty (DSAEK), states a paper in the journal Cornea.
|
|
|
|
KLAL significantly affected by adverse events
|
|
Keratolimbal allograft (KLAL) transplantation is affected by adverse events including immunologic rejections, chronic ocular surface exposure and graft-related complications, according to a study featured in Cornea.
|
|
|
|
FS-laer assisted intrastomal arcuate keratotomy a success
|
|
Intrastromal arcuate keratotomy performed with a femtosecond (FS) laser has an excellent safety profile, rapid recovery and stability of vision, claims a new paper.
|
|
|
|
Big bubble size can be safely increased
|
|
Undersized big-bubbles for DALK can safely be increased using blunt dissection for white-margin bubbles and ophthalmic viscosurgical device injection for clear-margin bubbles.
|
|
|
|
Mushroom configuration can perform corneal cuts
|
|
Femtosecond laser (FSL)-assisted mushroom configuration deep anterior lamellar keratoplasty (DALK) is reliable and reproducible, stated a recent noncomparative case series.
|
|
|
|
Eye viscosity increases with age
|
According to a paper published in Clinical and Experimental Ophthalmology, loss of energy due to elastic hysteresis positively correlates with age, leading to the belief that eye viscosity increases with age.
|
|
|
|
ICRS depth less than expected using OCT
|
|
Depth of intrastromal corneal ring segments (ICRS) is less than expected in myopic patients when measured by OCT, claims a recent paper.
|
|
|
|
OSST should be closely monitored for rejection
|
|
Ocular surface stem cell transplantation (OSST) patients should be closely monitored for rejection and compliance with immunosuppression.
|
|
|
|
MORE ARTICLES
|
|
|
|
|
|
Moria introduces single-use cataract instruments
|
|
The "One" range of single-use ophthalmic instruments has been introduced by Moria. The range comprises instruments commonly used during cataract surgery; instruments are available individually, or as part of a custom pack.
|
|
|
|
It's all changing at Zeiss
|
|
Recent acquisitions, division restructuring, and management changes prove that Carl Zeiss Meditec is very much committed to change. Ophthalmology Times Europe spoke with CEO, Dr Michael Kaschke about the challenges that he faces in an ever evolving market.
|
|
|
|
Femtosecond benefits in corneal procedures
|
|
Dr Rudi Nujits, presented new research on femtosecond laser assisted Descemet Stripping Endothelial Keratoplasty (FS-DSEK) at a session on the femtosecond laser and therapeutic corneal surgery.
|
|
|
|
Volk launches high resolution wide field lens
|
|
Volk Optical has launched the H-R Wide Field Laser Lens, a pan-retinal lens intended for diagnosis and PRP laser treatment.
|
|
|
|
Seiler vs Holladay: the presbyopia debate
|
|
The search for a presbyopic treatment that is universally effective and universally applicable is viewed in the industry and the profession as the holy grail because of the number of people in the presbyopic age group today.
|
|
|
|
Oertli proud of new 1.6 mm tip
|
|
Oertli proudly showcased their new product that enables coaxial microincision cataract surgery through 1.6 mm: the CO-MICS 2 tip is fully compatible with the firm's existing OS3, SwissTech and CataRhex platforms.
|
|
|
|
Femtosecond to fully replace microkeratome
|
|
The age of microkeratomes is coming to an end as femtosecond lasers come of age. That's the chief conclusion drawn by Dr Gunther Grabner, professor of ophthalmology at the Paracelsus University of Salzburg, in a survey on the advantages and limitations of femtosecond lasers.
|
|
|
|
Dry eye diagnostic coming to a clinic near you
|
|
OcuSense, makers of the innovative TearLab Osmolarity System for the diagnosis of dry eye, announced the signing of multi-year agreements with four distributors in five EU countries, for the exclusive distribution of the TearLab system.
|
|
|
|
Haag-Streit showcases comprehensive new optical biometer
|
|
Haag-Streit has taken the opportunity of the ESCRS meeting to unveil its innovative non-contact optical biometer, the LENSTAR LS900.
|
|
|
|
MORE ARTICLES
|
|
|
|
Berlin Beckons
|
|
Join OTE in booth BL10 at this year's ESCRS congress
|
|
|
|
Thank you!
|
|
Although we have always received a steady stream of feedback from readers, contributors and industry, never have we been bombarded by so many compliments in such a short space of time as at two recent conferences.
|
|
|
|
What do you want to see in OTE in 2009?
|
|
Fill in OTE's online readership survey for the chance to win €500 Marriott hotel vouchers.
|
|
|
|
The industry's evolving, so are we
|
|
Sometimes I sit back and think about how this magazine has evolved over the years and, on a more regular basis, I think about where we can go from here.
|
|
|
|
Micro innovations
|
|
In technological terms, when a word is prefixed by 'micro' you come to expect that word to signify some form of technological innovation or advance. In ophthalmology, the word 'microincision' represents significant advancement, particularly in the fields of cataract and vitreoretinal surgery.
|
|
|
|
World Glaucoma Day 2008: uniting to make a difference
|
|
The lack of public knowledge about glaucoma surprises me. Although pretty much everybody has heard of it, little is generally known other than the fact that it affects the eye.
|
|
|
|
LASIK: some still in the dark
|
|
I recently attended a party where I was drawn into a conversation by some people who had one thing in common – LASIK. Somebody amongst the group had undergone the procedure six years ago (incidentally, that was my sister) whilst another underwent wavefront-guided LASIK just weeks prior. Each of the four people had a story to tell about their experience with the procedure but, overall, each claimed they were happy with the end result.
|
|
|
|
Tempted by a free trip for two?
|
|
Tempted?
|
|
|
|
We invite you to have your say
|
|
When we launched Ophthalmology Times Europe (OTE) two years ago, our aim was always to provide a forum for ophthalmologists to communicate their knowledge, discoveries, experience and opinions. This aim has not changed. However, with the industry evolving at such a dramatic rate, it is difficult to convey the views and opinions of everyone who wants to be heard in our print publication. Help is at hand.
|
|
|
|
MORE ARTICLES
|
|
|
|
|
|
|
|
|
|
Review of the year 2010
|
|
A review of the year in cataract & refractive, retina and glaucoma. Shows three industry experts view on their highs of the year and the changes they've experienced as well as what the future holds for 2011
|
|
|
|
Two does become one
|
|
We report on the first cataract and refractive femtosecond laser
|
|
|
|
Mixing multifocal IOLs associated with high patient satisfaction
|
|
Using both diffractive and refractive IOLs in fellow eyes can result in excellent outcomes
|
|
|
|
IOL delivers on visual quality, acuity
|
|
Aberration-free optic
|
|
|
|
60 years of pioneering IOL innovation
|
|
Rayner Intraocular Lens Limited, has marked a milestone with a celebration to honour the 60th anniversary of the implantation of the first intraocular lens (IOL) in a patient. The late Sir Harold Ridley implanted the first IOL on 29 November 1949 at St. Thomas Hospital in London. Due to the controversial nature of the surgery, this first surgery was conducted in almost total secrecy.
|
|
|
|
Novel scleral lens proves cost-effective
|
|
In the December issue of the American Journal of Ophthalmology Brandeis University researchers published a paper about the highly precise scleral lens, to treat severe cornea or ocular surface disease, the Boston Ocular Surface Prosthesis (BOS-P).
|
|
|
|
Multifocal IOLs
|
|
Have a closer look at some of the multifocal IOLs available in Europe.
|
|
|
|
Monofocal IOLs
|
|
Take a look at some of the Monofocal IOLs available in Europe.
|
|
|
|
Accommodating IOLs
|
|
Accommodating IOLs are making a splash in Europe - why don't you take a closer look at some of them?
|
|
|
|
MORE ARTICLES
|
|
|
|
Point of care tear film test simplifies dry eye management
|
|
Diagnosing and managing dry eye patients can be challenging. Here Dr Philipp Steven looks at a new way of treating tear film osmolarity, the TearLab Osmolarity System, which he believes could dramatically simplify the process.
|
|
|
|
Clinical improvement in adenoviral conjunctivitis model
|
|
Foresight Biotherapeutics, Inc. has announced data from a pre-clinical study designed to assess the safety and efficacy of the topical administration of FST-100 in a highly regarded Ad5 NZW rabbit model of adenoviral conjunctivitis.
|
|
|
|
Novagali technologies allow greater drug access to the posterior of the eye
|
|
According to research analysts it is estimated that as little as five percent of a topically applied drug ever reaches the intraocular tissues due to drug loss as the result of tearing, lacrimal fluid-eye barriers, and blood-ocular barriers.
|
|
|
|
Liquid ocular bandage launched in Europe
|
|
BD OcuSeal Liquid Ocular Bandage, a fully synthetic protective barrier to be used for post-surgical, post-traumatic and non-traumatic ocular conditions, has been launched in Europe by BD Medical?Ophthalmic Systems.
|
|
|
|
Retisert implant in sympathetic ophthalmia
|
|
The fluocinolone acetonide (Retisert; Bausch & Lomb) surgical implant can prevent blindness in cases of sympathetic ophthalmia (SO), according to research at the University of Iowa, US.
|
|
|
|
Link between skin cancer and eye cancer
|
|
There is an association between uveal and a variety of skin melanomas, according to study results published in the March issue of Ophthalmology.
|
|
|
|
Uveitis study enters Phase IIa
|
|
ESBATech AG, a developer of antibody fragment therapeutics, has initiated a Phase IIa study in patients with acute anterior uveitis, designed to evaluate the safety, tolerability and clinical activity of topically applied ESBA105.
|
|
|
|
Causes of infectious scleritis
|
|
Fungus and microbial infection are the most common causes of infectious scleritis, according to study conclusions published in the February issue of Eye.
|
|
|
|
Anti-inflammatory enters Phase I/II
|
|
ESBA105, an anti-TNF alpha antibody fragment designed to reduce inflammation in patients undergoing cataract surgery, has begun a Phase Ib/IIa trial, according to an announcement from ESBATech AG, the antibody's developer.
|
|
|
|
MORE ARTICLES
|
|
|
|
Open your mind to a new philosophy
|
|
Didier Ducournau talks about the development and growth of the EVRS and on his personal vision for vitreoretinal surgeons.
|
|
|
|
The Italian pioneers
|
|
Surgeons should not feel ashamed if they only manage to see a few patients, devotion to the patient and then to your practice is of paramount importance. Then, and only then, will you be doing your job well.
|
|
|
|
European Society of Ophthalmology: the first 50 years
|
|
Since its inception in 1956, the European Society of Ophthalmology (SOE) has grown from a small entity into a conglomerate of national ophthalmological societies from all 40 European countries, representing more than 40,000 European ophthalmologists. We speak with President Zdenek Gregor about the changing face of the society, the importance of collaboration and the way the society has adapted to an ever-evolving Europe.
|
|
|
|
Learning to work together
|
|
1991 witnessed the birth of the European Society of Cataract and Refractive Surgeons (ESCRS); a new kind of society aimed at unifying specialists and societies across a number of disciplines throughout the continent. Society President, Professor Marie José Tassignon talks to OTE about her vision for the future.
|
|
|
|
MORE ARTICLES
|
|
|
|
Macular thickness increases after cataract surgery
|
|
Macular thickness significantly increases up to six months after uncomplicated cataract surgery, according to an investigation featured in the journal Eye.
|
|
|
|
Corneal degeneration is more common in white women
|
|
Peripheral hypertrophic subepithelial corneal degeneration is an uncommon disorder that occurs mostly in white women with a distinct phenotype, claims a study in the journal Ophthalmology.
|
|
|
|
Increased intake of carotenoids and fish oil doesn't reduce AMD risk further
|
|
Increased oral supplementation of carotenoids (lutein and zeaxanthin) and omega-3 fatty acids, found in fish oil, does not reduce the risk of AMD progression further to the original AREDS formulation, claims the latest results of the Age-Related Eye Disease Study (AREDS2).
|
|
|
|
Visual acuity poorly linked to GT after DSAEK
|
|
Visual acuity poorly correlates to graft thickness (GT) in patients who underwent descemet stripping automated endothelial keratoplasty (DSAEK), states a paper in the journal Cornea.
|
|
|
|
RDO patient pathway improves operative rates in cataracts
|
|
Operative rates for cataract surgery are higher for the refined direct optometrist (RDO) patient pathway, compared to the GP pathway, reveals a recent investigation in the UK.
|
|
|
|
Stepladder technique successful for malignant glaucoma
|
|
Malignant glaucoma can be successfully managed using the stepladder technique, including timely and appropriate interventions, claims a paper in the journal Ophthalmology.
|
|
|
|
DME patient treated with Iluvien
|
|
Iluvien has been used to treat a diabetic macular oedema (DME) patient in the UK since the product became commercially available, it was revealed in a press release this week.
|
|
|
|
Combined scleral buckle and BGI is effective
|
|
Combined scleral buckle and Baerveldt glaucoma implantation (BGI) is effective for managing coexisting glaucoma and retinal detachment.
|
|
|
|
KLAL significantly affected by adverse events
|
|
Keratolimbal allograft (KLAL) transplantation is affected by adverse events including immunologic rejections, chronic ocular surface exposure and graft-related complications, according to a study featured in Cornea.
|
|
|
|
MORE ARTICLES
|
|
|
|
Dear Editor
|
|
In answer to the question: "What specifically makes SLT different
from ALT in its action?" we offer the following response:
|
|
|
|
An African expedition
|
|
I embarked on a memorable trip to Africa recently and, along with a wonderful team of skilled ophthalmologists and nurses, we set up two eye camps in Namibia and Zambia. Our mission was to study corneal thickness in native Africans so that we could, in the future, establish the relationship between corneal thickness and glaucoma in this population.
|
|
|
|
MORE ARTICLES
|
|
|
|
Highlights from AAO 2007
|
|
Read Ophthalmology Times' extensive coverage from the 2007 annual meeting in New Orleans, USA.
|
|
|
|
Highlights from the ESCRS Congress 2007
|
|
Read Ophthalmology Times Europe's extensive coverage from the 2007 annual meeting in Stockholm, Sweden.
|
|
|
|
IGS 2007 Meeting Highlights
|
|
Athens played host to the sixth annual International Glaucoma Society (IGS) congress, which ran from 28-31 March. Attended by more than 2,650 participants from around the world, the meeting earned the title of the most attended international glaucoma meeting ever held.
|
|
|
|
Meeting highlights from the AAO annual congress 2006, Las Vegas, 11-14 November
|
|
More prospective studies are needed to evaluate the role of diurnal and long-term intraocular pressure (IOP) function in glaucoma development and progression, according to Felipe A. Medeiros, MD, PhD, assistant professor of ophthalmology, University of California at San Diego, USA, speaking at the glaucoma subspecialty session.
|
|
|
|
Parameters for defining quality of vision
|
|
According to Oliver Findl, it is becoming increasingly important to use a wider variety of parameters to assess visual quality after cataract surgery in order to gain a better understanding of patient's day-to-day experiences.
|
|
|
|
Wavelight announces two IOL approvals
|
|
Wavelight has announced the receipt of two regulatory approvals for its intraocular lenses (IOLs), thus expanding its intraocular product range.
|
|
|
|
Levofloxacin should be the first choice for antibacterial prophylaxis
|
|
Levofloxacin 0.5% eye drops should be the first choice for antibacterial prophylaxis and treatment, according to Professor P. Asbell of the Mount Sinai School of Medicine, USA.
|
|
|
|
MICS has made very little impact on US and EU surgeon practice
|
|
Microincision cataract surgery (MICS), hailed to be the next big development in cataract surgery, has not had the expected impact on surgeon's practice, David Leaming revealed, whilst detailing the results of his most recent survey on cataract surgery practice in Europe and the US.
|
|
|
|
Foldable toric IOL safe and effective in high astigmatism
|
|
According to Omid Kermani from the Augenabteilung der PAN-Klinik am Neumarkt, Köln, Germany, and colleagues, the implantation of a foldable toric intraocular lens (IOL) is a safe and predictable procedure for the correction of high pre-existing corneal astigmatism in cataract surgery.
|
|
|
|
MORE ARTICLES
|
|
|
|
|
|
|
|
Product Profiles
|
|
A round up of new products
|
|
|
|
Product Profiles
|
|
A round up of new products
|
|
|
|
IQ 577 laser system now available to doctors
|
|
Iridex has commenced shipment of its IQ 577 laser systems which is designed to treat vision-threatening eye diseases such as diabetic retinopathy, age-related macular degeneration and glaucoma.
|
|
|
|
A comparison of six OCT devices
|
|
In a head-to-head comparison of six OCT devices, the Spectralis spectral domain OCT (Heidelberg Engineering) showed the lowest co-efficient of variation in a test-retest study.
|
|
|
|
Clinical trials show promise to help mydriasis during cataract surgery
|
|
Results from the Omeros Corporation for the Phase I/Phase II clinical trial of OMS302, a proprietary combination of an anti-inflammatory agent and an agent that causes pupil dilation (mydriasis) are said to be promising.
|
|
|
|
NicOx reacquires rights to PF-03187207 for glaucoma from Pfizer
|
|
NicOx S.A. has signed an agreement with Pfizer Inc to reacquire the full development and commercialization rights to PF-03187207, which has completed two phase II studies in patients with primary open angle glaucoma and ocular hypertension. As part of this agreement, Pfizer has granted NicOx the right to access and use certain proprietary Xalatan (latanoprost) data.
|
|
|
|
Ketolorac tromethamine should be available in September
|
|
Allergan Inc. expects its ketorolac tromethamine ophthalmic solution 0.45% (Acuvail) to be available in the United States in September. The preservative-free formulation of ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), is indicated for the treatment of pain and inflammation after cataract surgery and received FDA approval at the end of July, the company announced.
|
|
|
|
Implant with potential to permanently treat glaucoma
|
|
OcumatRx, an early stage company that is developing a medical device that represents a new concept for the permanent treatment of patients with glaucoma, has announced the successful completion of clinical trials for their first device with favourable preliminary safety and tolerability.
|
|
|
|
Alcon discontinues development of anecortave acetate for IOP reduction
|
|
Alcon Inc. announced it has discontinued development of anecortave acetate for the reduction of IOP associated with glaucoma.
|
|
|
|
MORE ARTICLES
|
|
|
|
Safety first: pIOL is effective for myopic astigmatism
|
|
Implantation of the Artiflex toric iris-fixated phakic IOL is effective, predictable and safe for the correction of myopic astigmatism.
|
|
|
|
Inhibiting and regressing corneal neovascularisation
|
|
Interim results from a Phase II study by Gene Signal suggest that antisense oligonucleotide GS-101 is safe and effective at inhibiting abnormal corneal new blood vessel growth.
|
|
|
|
Glaucoma related to selenium levels
|
|
The pathology of glaucoma is likely to be related to the presence and levels of selenium, according to the results of a study published in the August issue of the British Journal of Ophthalmology.
|
|
|
|
The brain predicts what moving eyes will see
|
|
A new study conducted by researchers at the University of Aberdeen, Scotland, has found that the brain predicts the consequences of eye movement even before the eyes take in a new scene.
|
|
|
|
Lowering levels of arginase may halt progression of diabetic retinopathy
|
|
High levels of the enzyme arginase contributes to vascular eye damage, and therapies to lower its levels could halt progression of diabetic retinopathy (DR), according to researchers at the Medical College of Georgia (MCG) School of Medicine, USA.
|
|
|
|
When can an eye growth transform into melanoma?
|
|
According to a report in the August issue of Archives of Ophthalmology, there are eight factors that may predict whether a choroidal nevus-a benign, flat, pigmented growth inside the eye and beneath the retina-may develop into melanoma.
|
|
|
|
Gene therapy delivers bonus results
|
|
Partial sections of vision were recently restored to a blind woman's retina through the use of gene therapy.
|
|
|
|
Researchers uncover genetic link to age-related cataracts
|
|
Researchers in Cleveland have discovered the first gene associated with the formation of age-related cataracts. EphA2 encodes an enzyme that plays a role in the repair of proteins in the lens of the eye after they become damaged and clump together, according to the investigators.
|
|
|
|
Implant with potential to permanently treat glaucoma
|
|
OcumatRx, an early stage company that is developing a medical device that represents a new concept for the permanent treatment of patients with glaucoma, has announced the successful completion of clinical trials for their first device with favourable preliminary safety and tolerability.
|
|
|
|
MORE ARTICLES
|
|
|
|
The what, who and why of stem cells in ophthalmology: Part 1
|
|
Ophthalmic blogger, Irv Arons writes a tell all on what stem cells are all about, who's involved, who they are collaborating with, what type of stem cells they are using and what diseases they are aimed at.
|
|
|
|
A vision for the world
|
|
Helping others to help themselves
|
|
|
|
Contact induced dry eye
|
|
Understanding the problems of contact lens induced dry eye
|
|
|
|
The ideal drop through the eyes of doctors and patients
|
|
Five steps and the criteria for success, as seen through the eyes of patients and their doctors...
|
|
|
|
OTE at the WOC
|
|
The Ophthalmology TImes Europe team is looking forward to meeting many readers and customers at the Congress and to bringing you coverage of the event and new developments emerging from it.
|
|
|
|
Standardizing trauma terminology
|
|
A standardized language of trauma classification can have value for prognosis as well as description, according to Dr Dante Pieramici.
|
|
|
|
Flying eye hospital gets new aeroplane
|
|
Orbis International, an international nonprofit humanitarian organization which operates the world"s only Flying Eye Hospital, is to upgrade from a DC-10-10 to a DC-10 Series 30 freighter airline, giving the project an extra 20 years of flying time.
|
|
|
|
Should tear dysfunction be treated with nutritional supplements?
|
|
Nutritional supplements seem to make sense as a treatment of tear dysfunction, according to Marian Macsai, MD. Dr Macsai tempered her assertion with the observation that no objective trials have been performed to support the use of nutritional supplements in patients with tear deficiency.
|
|
|
|
Minimally invasive strabismus surgery vs the limbal approach
|
|
As with all medical disciplines, the goal of every surgeon is to perform surgery that is minimally invasive, in order to reduce the risk of unwanted complications and a poor postoperative appearance, and to increase patient comfort and satisfaction.
|
|
|
|
MORE ARTICLES
|
|
|
|
BTA injections can treat infantile esotropia
|
|
Botulinum toxin type A (BTA) injections, with or without sodium hyaluronate (SH), are effective and feasible for the treatment of infantile esotropia.
|
|
|
|
IOP lowered with trab and combination trab
|
|
IOP is successfully reduced with both trabeculectomy and combined trabeculotomy-trabeculectomy with mitomycin C in children with glaucoma.
|
|
|
|
Maternal malnutrition is keratomalacia risk factor
|
|
Keratomalacia can be linked to lower socioeconomic status, poor maternal nutrition, and inadequate breastfeeding.
|
|
|
|
OTS is reliable in predicting paediatric cataract visual outcome
|
|
The Ocular Trauma Score (OTS) is a reliable predictor of final visual outcome in children with traumatic cataract
|
|
|
|
Anterior and posterior capsulorhexis in children
|
|
Anterior and posterior capsulorhexis in children
|
|
|
|
Paediatric ophthalmology conference programme
|
|
The Egyptian Group of Paediatric Eye Surgery (EGPES) will be hosting the 4th International Symposium of Paediatric Ophthalmology, from 4th to 6th of November 2009, in Alexandria, Egypt.
|
|
|
|
A clinical conundrum
|
|
According to the J Pediatr Ophthalmol Strabismus 2009;46:238-240 optic disc oedema is a clinical conundrum which has potential to delay diagnosis and therefore treatment of idiopathic intracranial hypertension.
|
|
|
|
Link between ROP and haemangioma in low birth-weight infants discovered
|
|
In infants with birth weights of 1250 g, haemangiomas are associated with the development of retinopathy of prematurity (ROP), according to study data published in the March 2009 issue of Pediatrics.
|
|
|
|
US introduces law protecting children's vision
|
|
The Vision Care for Kids Bill of 2009, legislation to provide vision care to children without health insurance, has been introduced in the US after being approved both by the Senate and by the House of Representatives.
|
|
|
|
MORE ARTICLES
|
|
|
|
Safety first: pIOL is effective for myopic astigmatism
|
|
Implantation of the Artiflex toric iris-fixated phakic IOL is effective, predictable and safe for the correction of myopic astigmatism.
|
|
|
|
IOL power: Quo vadis?
|
|
Increasing levels of expectations of refractive results is challenging IOL power calculations, reveals Dr Oliver Findl
|
|
|
|
Optical Biometry
|
|
Dr Paul-Rolf Preussner discusses how additional optical measurements are required to improve the accuracy limits in IOL calculation
|
|
|
|
New frontiers in IOL power calculations
|
|
Following a premium IOL implantation it is now possible to maintain the target refractive error of 0.5 D but errors can still arise in the calculation of the desired IOL power. Modernizing formulae may help to reduce prediction error in IOL power calculations.
|
|
|
|
Laser capsulotomy yields predictability
|
|
An investigational femtosecond laser-assisted cataract surgery system for capsulotomy creation was evaluated in a randomized, fellow eye control study.
|
|
|
|
Debate: Best appraoch to thin cornea
|
|
Refractive specialists weigh in with views on surface ablation versus the flap-based procedure.
|
|
|
|
Be aware of potential IOL complications
|
|
The potential complications associated with implantation of phakic IOLs may give cataract surgeons a few challenges, but problems can often be averted with proper sizing and vaulting.
|
|
|
|
Review of the year 2010
|
|
A review of the year in cataract & refractive, retina and glaucoma. Shows three industry experts view on their highs of the year and the changes they've experienced as well as what the future holds for 2011
|
|
|
|
Femtosecond facilitates 'big bubble'
|
|
A new variation of femtosecond laser-assisted 'big bubble' deep anterior lamellar keratoplasty uses the laser to create an intrastromal channel serves as a pathway for the insertion of the air injection
|
|
|
|
MORE ARTICLES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
